Wei-Wu He Insider Trading $CASI CASI Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Wei-Wu He.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Wei-Wu He. Wei-Wu He is CEO in CASI Pharmaceuticals, Inc. ($CASI) and Chairman and CEO in CASI Pharmaceuticals, Inc. ($CASI) and Chief Executive Officer in CASI Pharmaceuticals, Inc. ($CASI) and Director in CASI Pharmaceuticals, Inc. ($CASI).
Wei-Wu He in CASI Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Wei-Wu He: Chairman and CEO, Chief Executive Officer, CEO, Director
Holdings: 3,000,000 shares
Current Value: $4,170,000
Latest Transaction: Mar 30 2021
$CASI Market Capitalization: $81.26M
$CASI Previous Close: $1.39
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Wei-Wu He in CASI Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.05 | 3,000,000 | 6,150,000 | 3,000,000 | 0 to 3 M |
| Dec 23 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Gift | G | 0.00 | 380,000 | 0 | 4,683,994 | 5.1 M to 4.7 M (-7.50 %) |
| Nov 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.18 | 100,000 | 218,000 | 5,063,994 | 5 M to 5.1 M (+2.01 %) |
| Nov 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.12 | 127,471 | 270,239 | 4,963,994 | 4.8 M to 5 M (+2.64 %) |
| Jul 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.90 | 1,200,000 | 2,280,000 | 7,532,347 | 6.3 M to 7.5 M (+18.95 %) |
| Jul 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.90 | 2,952,426 | 5,609,609 | 4,836,523 | 1.9 M to 4.8 M (+156.70 %) |
| May 21 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.37 | 56,464 | 133,820 | 1,884,097 | 1.8 M to 1.9 M (+3.09 %) |
| May 21 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.03 | 29,801 | 60,496 | 1,827,663 | 1.8 M to 1.8 M (+1.66 %) |
| May 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.02 | 338,932 | 684,643 | 1,797,832 | 1.5 M to 1.8 M (+23.23 %) |
| May 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.82 | 100,000 | 182,000 | 1,458,900 | 1.4 M to 1.5 M (+7.36 %) |
| Mar 30 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.08 | 6,880 | 14,310 | 1,358,900 | 1.4 M to 1.4 M (+0.51 %) |
| Mar 27 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.09 | 328,095 | 685,719 | 1,352,020 | 1 M to 1.4 M (+32.04 %) |
| Mar 27 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.94 | 196,398 | 381,012 | 1,023,925 | 827.5 K to 1 M (+23.73 %) |
| Mar 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.57 | 234,488 | 368,146 | 6,332,347 | 6.1 M to 6.3 M (+3.85 %) |
| Mar 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.52 | 501,322 | 762,009 | 6,097,859 | 5.6 M to 6.1 M (+8.96 %) |
| Mar 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.50 | 264,192 | 396,288 | 5,596,537 | 5.3 M to 5.6 M (+4.95 %) |
| Dec 18 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Option Exercise | X | 1.69 | 374,321 | 632,602 | 0 | |
| Dec 18 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | X | 1.69 | 374,321 | 632,602 | 5,332,345 | 5 M to 5.3 M (+7.55 %) |
| Aug 20 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chief Executive Off ... | Buy | P | 3.20 | 20,000 | 64,000 | 827,527 | 807.5 K to 827.5 K (+2.48 %) |
| Aug 15 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chief Executive Off ... | Buy | P | 3.17 | 160,000 | 507,200 | 807,527 | 647.5 K to 807.5 K (+24.71 %) |
| Jun 21 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | CEO | Option Exercise | A | 2.85 | 4,000,000 | 11,400,000 | 4,000,000 | |
| Dec 21 2018 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Gift | G | 0.00 | 200,000 | 0 | 647,527 | 847.5 K to 647.5 K (-23.60 %) |
| Jun 12 2018 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 3.22 | 1,000,000 | 3,220,000 | 1,000,000 | |
| Mar 21 2018 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 3.69 | 1,234,567 | 4,555,552 | 1,234,567 | |
| Mar 21 2018 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 3.24 | 3,086,419 | 9,999,998 | 4,958,024 | 1.9 M to 5 M (+164.91 %) |
| Oct 11 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.95 | 100,000 | 195,000 | 847,527 | 747.5 K to 847.5 K (+13.38 %) |
| Oct 10 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.86 | 100,000 | 186,000 | 747,527 | 647.5 K to 747.5 K (+15.44 %) |
| Oct 10 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.80 | 100,000 | 180,000 | 647,527 | 547.5 K to 647.5 K (+18.26 %) |
| Sep 20 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.78 | 34,002 | 60,524 | 547,527 | 513.5 K to 547.5 K (+6.62 %) |
| Sep 20 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.75 | 173,500 | 303,625 | 513,525 | 340 K to 513.5 K (+51.03 %) |
| Sep 18 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.49 | 127,702 | 190,276 | 340,025 | 212.3 K to 340 K (+60.15 %) |
| Sep 18 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.22 | 187,625 | 228,903 | 212,323 | 24.7 K to 212.3 K (+759.68 %) |
| Jun 09 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.01 | 100,000 | 100,640 | 100,000 | |
| Oct 25 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.40 | 202,247 | 283,146 | 202,247 | |
| Oct 05 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.69 | 374,321 | 632,602 | 374,321 | |
| Oct 05 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.11 | 366,343 | 406,641 | 366,343 | |
| Oct 05 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.19 | 1,871,605 | 2,227,210 | 1,871,605 | 0 to 1.9 M |
| Jul 06 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.10 | 84,507 | 92,958 | 84,507 | |
| Jun 27 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.15 | 369,805 | 425,276 | 369,805 | |
| Jun 03 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 0.86 | 712,112 | 612,488 | 712,112 | |
| Mar 04 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 0.88 | 100,000 | 88,000 | 100,000 | |
| Apr 08 2015 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.41 | 100,000 | 141,000 | 100,000 |
Page: 1